Companies House does not verify the accuracy of the information filed

CLOVER BIOPHARMACEUTICALS UK LTD

Company number 13677744

Follow this company File for this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
19 Apr 2024	AP01	Appointment of Mr Peng Liang as a director on 8 April 2024	View PDF Appointment of Mr Peng Liang as a director on 8 April 2024 - link opens in a new window - 2 pages (2 pages)
19 Apr 2024	TM01	Termination of appointment of Nicholas Aubrey Corbett Jackson as a director on 8 April 2024	View PDF Termination of appointment of Nicholas Aubrey Corbett Jackson as a director on 8 April 2024 - link opens in a new window - 1 page (1 page)
23 Jan 2024	SH01	Statement of capital following an allotment of shares on 18 January 2024 GBP 475	View PDF Statement of capital following an allotment of shares on 18 January 2024 GBP 475 - link opens in a new window - 3 pages (3 pages)
23 Jan 2024	AP01	Appointment of Mr Joshua Liang as a director on 9 January 2024	View PDF Appointment of Mr Joshua Liang as a director on 9 January 2024 - link opens in a new window - 2 pages (2 pages)
18 Dec 2023	CS01	Confirmation statement made on 16 December 2023 with updates	View PDF Confirmation statement made on 16 December 2023 with updates - link opens in a new window - 5 pages (5 pages)
16 Oct 2023	AA	Full accounts made up to 31 December 2022	View PDF Full accounts made up to 31 December 2022 - link opens in a new window - 26 pages (26 pages)
07 Feb 2023	SH01	Statement of capital following an allotment of shares on 3 February 2023 GBP 425	View PDF Statement of capital following an allotment of shares on 3 February 2023 GBP 425 - link opens in a new window - 3 pages (3 pages)
05 Jan 2023	CS01	Confirmation statement made on 16 December 2022 with updates	View PDF Confirmation statement made on 16 December 2022 with updates - link opens in a new window - 5 pages (5 pages)
04 Jan 2023	TM01	Termination of appointment of Qi Liang as a director on 31 December 2022	View PDF Termination of appointment of Qi Liang as a director on 31 December 2022 - link opens in a new window - 1 page (1 page)
23 Sep 2022	CH01	Director's details changed for Mr Nicholas Aubrey Corbett Jackson on 12 September 2022	View PDF Director's details changed for Mr Nicholas Aubrey Corbett Jackson on 12 September 2022 - link opens in a new window - 2 pages (2 pages)
23 Sep 2022	CH01	Director's details changed for Mr Nicholas Aubrey Corbett on 12 September 2022	View PDF Director's details changed for Mr Nicholas Aubrey Corbett on 12 September 2022 - link opens in a new window - 2 pages (2 pages)
23 Sep 2022	AP01	Appointment of Mr Nicholas Aubrey Corbett as a director on 12 September 2022	View PDF Appointment of Mr Nicholas Aubrey Corbett as a director on 12 September 2022 - link opens in a new window - 2 pages (2 pages)
21 Sep 2022	CH01	Director's details changed	View PDF Director's details changed - link opens in a new window - 2 pages (2 pages)
16 Sep 2022	TM01	Termination of appointment of Andrew John Baker as a director on 16 September 2022	View PDF Termination of appointment of Andrew John Baker as a director on 16 September 2022 - link opens in a new window - 1 page (1 page)
22 Aug 2022	SH01	Statement of capital following an allotment of shares on 19 August 2022 GBP 200	View PDF Statement of capital following an allotment of shares on 19 August 2022 GBP 200 - link opens in a new window - 3 pages (3 pages)
03 Aug 2022	MR01	Registration of charge 136777440001, created on 25 July 2022	View PDF Registration of charge 136777440001, created on 25 July 2022 - link opens in a new window - 13 pages (13 pages)
13 May 2022	AA01	Current accounting period extended from 31 October 2022 to 31 December 2022	View PDF Current accounting period extended from 31 October 2022 to 31 December 2022 - link opens in a new window - 1 page (1 page)
11 Mar 2022	PSC04	Change of details for Mr Joshua Liang as a person with significant control on 11 March 2022	View PDF Change of details for Mr Joshua Liang as a person with significant control on 11 March 2022 - link opens in a new window - 2 pages (2 pages)
22 Dec 2021	SH01	Statement of capital following an allotment of shares on 16 December 2021 GBP 100	View PDF Statement of capital following an allotment of shares on 16 December 2021 GBP 100 - link opens in a new window - 3 pages (3 pages)
22 Dec 2021	CS01	Confirmation statement made on 16 December 2021 with updates	View PDF Confirmation statement made on 16 December 2021 with updates - link opens in a new window - 5 pages (5 pages)
28 Oct 2021	PSC07	Cessation of Andrew John Baker as a person with significant control on 27 October 2021	View PDF Cessation of Andrew John Baker as a person with significant control on 27 October 2021 - link opens in a new window - 1 page (1 page)
28 Oct 2021	PSC01	Notification of Joshua Liang as a person with significant control on 27 October 2021	View PDF Notification of Joshua Liang as a person with significant control on 27 October 2021 - link opens in a new window - 2 pages (2 pages)
19 Oct 2021	AP01	Appointment of Miss Qi Liang as a director on 18 October 2021	View PDF Appointment of Miss Qi Liang as a director on 18 October 2021 - link opens in a new window - 2 pages (2 pages)
13 Oct 2021	NEWINC	Incorporation MODEL ARTICLES ‐ Model articles adopted (Amended Provisions) Statement of capital on 2021-10-13 GBP 10	View PDF Incorporation MODEL ARTICLES ‐ Model articles adopted (Amended Provisions) Statement of capital on 2021-10-13 GBP 10 - link opens in a new window - 33 pages (33 pages)

Cookies on Companies House services

CLOVER BIOPHARMACEUTICALS UK LTD

Filter by category